¥ÿÿw逺à |/¨Â52²‹ ­ ½üÖ ªª—„pSÕÀÿ‡Ÿ~ùí ¿þñ¯ÿüïï% p³%ú 6bÔ˜q &M™6cÖœy -Y¶bÕšu 6mÙ¶cמ} 9vâÔ™s .]¹vãÖ { =yöÂK¯¼öÆ[ï¼÷ÁGŸ ...

extended-release tablets for the treatment of Prader-Willi syndrome (PWS) in individuals four years and older who have hyperphagia. The new Prescription Drug User Fee Act (PDUFA) target action ...

The Liberia Intellectual Property Office (LIPO) will today close its three-month public awareness campaign on promoting respect for intellectual property (IP) rights among the public. The campaign, ...

Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for ...

announced today that it has launched fibroblast growth factor receptor (FGFR) selective tyrosine kinase inhibitor “TASFYGO® Tablets 35mg” (generic name: tasurgratinib succinate) in Japan for the ...